Andrew Morozov
Private Equity Investor bei CISCO SYSTEMS, INC.
Profil
Andrew Morozov is currently an Independent Director at CureLab Oncology, Inc., a Corporate Business Development & Investment Manager at Cisco Systems, Inc., and a Partner at Gauss Ventures Ltd.
He previously worked as a Principal at TL Ventures, Inc. from 2000 to 2004.
Dr. Morozov holds an MBA degree from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Andrew Morozov
| Unternehmen | Position | Beginn |
|---|---|---|
| CISCO SYSTEMS, INC. | Private Equity Investor | - |
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Gauss Ventures Ltd.
 Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Private Equity Investor | 01.02.2018 |
Ehemalige bekannte Positionen von Andrew Morozov
| Unternehmen | Position | Ende |
|---|---|---|
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 01.01.2004 |
Ausbildung von Andrew Morozov
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Technology Services |
| Private Unternehmen | 3 |
|---|---|
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
Gauss Ventures Ltd.
Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Finance |
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
